Announcements Trials
Browse Landscape

Phase

Phase 3 19Phase 2 15Phase NA 5Phase 1 5Phase 1/2 3

Status

Withdrawn 1Terminated 1Completed 1

Sponsor Class

OTHER 7NIH 6NETWORK 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Prostatic Neoplasms 1Pancreatic Neoplasms 1Central Nervous System Neoplasms 1Brain Neoplasms 1

Interventions

Radiotherapy 13Cisplatin 8Cytarabine 7carfilzomib 5Specimen Handling 5Paclitaxel 5Dexamethasone 5Methotrexate 4Lapatinib 4Gemcitabine 4Fluorouracil 4Docetaxel 4Brachytherapy 4Biopsy 4venetoclax 3pomalidomide 3Temozolomide 3Radiotherapy, Conformal 3Leucovorin 3Irinotecan 3Etoposide 3Cyclophosphamide 3Carboplatin 3neratinib 2merphos 2Vincristine 2Radiation 2Polymerase Chain Reaction 2Oxaliplatin 2Immunohistochemistry 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1/2 × NETWORK × Radiotherapy, Conformal × Clear all
NCT00002602 2020-01-10

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Radiation Therapy Oncology Group

Phase 1/2 Completed
1,084 enrolled
Genitourinary

Prostatic Neoplasms

NCT00107471 2013-12-10

Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma

Children's Oncology Group

Phase 1/2 Terminated
7 enrolled
CNS

Brain Neoplasms, Central Nervous System Neoplasms

NCT01017822 2013-06-24

Conatumumab, Gemcitabine Hydrochloride, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Radiation Therapy Oncology Group

Phase 1/2 Withdrawn
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡